Today is: April 15, 2011

Evaluate Your Case Today







Calcagno & Associates

900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
             (718) 568-3585


By appointment only

Battery Place
New York, NY, 10004
Phone: (800) 933-4448

Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448

Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837


Name (First & Last)
DOB (Victims Date of Birth)

Phone

Email Address

Address

City

State

ZipCode

Message about your case

Crestor

In August of 2003, the United States Food and Drug Administration (FDA) approved Crestor, the latest in a series of cholesterol-reducing drugs called statins. Like the other six statins to enter the US market, Crestor is approved for use only in conjunction with a low-cholesterol diet and an exercise program designed to lower cholesterol. Crestor is only available in doses of 5, 10, 20, and 40 milligrams. The 40 milligram dose of Crestor is only available to patients who meet special restrictions.

According to drug manufacturer AstraZeneca, Crestor works by lowering the total cholesterol in the bloodstream, as well as a form of fat known as triglycerides. Crestor also increases the amount of HDL cholesterol (called “good cholesterol”) in the blood. AstraZeneca also warns that taking Crestor with certain other medications (including antacids) could lead to serious complications. Although the manufacturer’s web site states that Crestor side effects include nausea, constipation, stomach pain, weakness and muscle pain, it does not list the most deadly potential side effect of Crestor: kidney failure brought on by a type of muscle damage known as rhabdomyolysis.

In March 2004, the Public Citizen consumer group called on the FDA to immediately remove Crestor from the market because its link to cases of life-threatening muscle damage and kidney failure or damage. In the group’s press release it said, ” Since it was approved just over five months ago, three patients in the United States who were taking approved doses of rosuvastatin developed kidney failure or muscle damage. One of those patients, a 39-year-old woman, died of kidney failure and rhabdomyolysis, or muscle damage. Data obtained from the United States, the United Kingdom and Canada show seven cases of rhabdomyolysis and nine case of kidney damage or failure occurred after FDA approval.” The press release can be found here.

While AstraZeneca continues to tout Crestor as a miracle drug for the treatment of cholesterol problems, the potential side effects are potentially devastating. If you or a loved one is taking Crestor and suffering from adverse effects, you may wish to contact an attorney to receive a legal evaluation. Crestor users should watch for muscle pain, weakness, tenderness, malaise, fever, dark urine, nausea, and vomiting-all symptoms of rhabdomyolysis. Makers of Crestor may be held liable for the costs arising from muscle damage and/or kidney failure caused by the use of Crestor. An attorney with experience in drug litigation will be able to give you the proper legal advice regarding the use of Crestor and potential damages.

Please contact our lawyers if you would like more information on your legal rights and options.

Return to Defective Drugs Listing

 

Keywords | Articles | Locations | Coupons |